In an elderly woman with dementia who experiences recurrent falls from bed and wheelchair while taking melatonin twice daily, should the melatonin be discontinued?

Yes, discontinue the melatonin immediately in this elderly woman with dementia and recurrent falls.

The American Academy of Sleep Medicine strongly recommends avoiding melatonin in elderly patients with dementia who have irregular sleep-wake rhythm disorder (ISWRD), and this recommendation is even more compelling given her documented history of recurrent falls 1.

Why Melatonin Should Be Stopped

Lack of Efficacy

• Melatonin has failed to improve sleep outcomes in elderly patients with dementia across multiple randomized controlled trials 1
• Studies using doses up to 10 mg showed no significant improvement in total nocturnal sleep time, sleep efficiency, or number of nighttime awakenings 2
• The evidence quality is LOW, but consistently shows no benefit 1

Potential for Harm

The guideline evidence reveals concerning safety signals:

• One study documented detrimental effects on mood and daytime functioning with melatonin use in dementia patients 1
• The risk-benefit ratio clearly favors discontinuation, as potential harms outweigh any possible benefits 1
• Falls are already a documented problem in this patient, and adding any sleep-promoting medication increases fall risk in elderly dementia patients 1

Guideline Strength

The American Academy of Sleep Medicine provides a WEAK AGAINST recommendation specifically for melatonin in elderly dementia patients with sleep disturbances 1. While not as strong as their recommendation against other hypnotics (which is STRONG AGAINST), the evidence base and clinical experience suggest "the majority of older patients with dementia and/or their caregivers would not favorably accept a trial of melatonin" 1.

Critical Context: The Twice-Daily Dosing Red Flag

The prescription of melatonin twice daily is inappropriate regardless of the fall history. Melatonin should only be administered once daily at bedtime for circadian rhythm regulation 1. Twice-daily dosing:

• Has no evidence base in dementia
• May worsen daytime sedation
• Could contribute to fall risk through increased daytime sleepiness
• Suggests the medication was prescribed without proper understanding of its mechanism

What to Do Instead

Immediate Actions

1. Discontinue melatonin - taper not required as it's not habit-forming 3
2. Assess fall risk comprehensively - evaluate medication burden, muscle weakness, environmental hazards, and gait stability 4
3. Review all medications for polypharmacy and deprescribing opportunities, as this is strongly recommended in dementia with frailty 4

Alternative Sleep Management

If sleep disturbance remains problematic after discontinuation:

Consider light therapy (WEAK FOR recommendation):

• 2500-5000 lux broad-spectrum light
• 1-2 hours duration
• Morning timing (09:00-11:00)
• 4-10 week trial period 1
• This has modest evidence for benefit in elderly dementia patients with ISWRD 1

Avoid other sleep-promoting medications - The AASM has a STRONG AGAINST recommendation for hypnotics in elderly dementia patients due to increased fall risk and adverse outcomes 1

Address Fall Prevention

Given the recurrent falls, implement multimodal fall prevention 4:

• Physical exercise (balance, strength training)
• Environmental modifications (bed rails, wheelchair safety features)
• Vision and hearing assessment
• Medication review for drugs that impair balance or cause orthostatic hypotension

Common Pitfalls to Avoid

1. Don't substitute another sedative-hypnotic - benzodiazepines and Z-drugs carry even higher fall risk in this population 1
2. Don't continue melatonin "because it can't hurt" - the evidence shows it can cause harm in dementia patients 1
3. Don't ignore the underlying sleep disorder - address circadian rhythm disruption with non-pharmacological approaches first 1
4. Don't overlook depression - mood disorders are common in dementia and can worsen both sleep and fall risk 4

The evidence is clear: melatonin provides no benefit for sleep in elderly dementia patients while carrying potential risks for harm, particularly in someone already experiencing falls. Discontinuation is the appropriate clinical decision 1.